Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion dependent beta thalassaemia: a cross sectional study

View ORCID ProfilePadmapani Padeniya, View ORCID ProfileDileepa Ediriweera, Arjuna De Silva, View ORCID ProfileMadunil Niriella, View ORCID ProfileAnuja Premawardhena
doi: https://doi.org/10.1101/2022.01.15.22269369
Padmapani Padeniya
1Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
2Hemas Hospital, Wattala, Sri Lanka
3Adolescent and Adult Thalassaemia Care Center (University Medical Unit), North Colombo Teaching Hospital, No. 10, Sirima Bandaranayake Mawatha, Kadawatha, Kadawatha, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Padmapani Padeniya
  • For correspondence: padmapani@kln.ac.lk
Dileepa Ediriweera
1Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dileepa Ediriweera
Arjuna De Silva
1Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
4Nawaloka Hospital PLC, Colombo, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madunil Niriella
1Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Madunil Niriella
Anuja Premawardhena
1Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka
3Adolescent and Adult Thalassaemia Care Center (University Medical Unit), North Colombo Teaching Hospital, No. 10, Sirima Bandaranayake Mawatha, Kadawatha, Kadawatha, Sri Lanka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anuja Premawardhena
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To evaluated the performance of FIB-4 score as a screening tool to detect significant liver fibrosis (F2) compared to transient elastography (TE), among chronic transfusion-dependent beta-thalassemia (TDT) patients, in a resource-poor setting.

Design A cross-sectional study

Setting Adolescent and Adult Thalassaemia Care Center (University Medical Unit), Kiribathgoda, Sri Lanka.

Participants 45 TDT patients who have undergone more than 100 blood transfusions with elevated serum ferritin >2000ng/mL, were selected for the study. Patients who were serologically positive for hepatitis C antibody were excluded.

Outcome measures TE and FIB-4 score were estimated at the time of recruitment in all participants. Pre-defined cut-off values for F2, extracted from previous studies for TE and FIB-4 score, were compared. A new cut-off value for FIB-4 score was estimated using ROC curve analysis to improve the sensitivity for F2 prediction.

Results Of the selected 45 TDT patients, 22(49%) were males. FIB-4 score showed a significant linear correlation with TE (r= 0.52;p< 0.0003). The FIB-4 score was improbable to lead to a false classification of TDT patients to have F2 when the FIB-4 cut-off value was 1.3. On the other hand, it had a very low diagnostic yield in missing almost all (except one) of those who had F2. Using a much-lowered cut-off point of 0.32 for FIB-4, we improved the pick-up rate of F2 to 72%.

Conclusions Regardless of the cut-off point, FIB-4 score cannot be used as a good screening tool to pick-up F2 in patients with TDT, irrespective of their splenectomy status. On the contrary, at 1.3 cut off value though FIB-4 is a very poor detector for F2 fibrosis it will not erroneously diagnose F2 fibrosis in those who don’t have it.

Strengths and limitations of this study

  • There is limited information available on the applicability of FIB-4 score to assess significant liver fibrosis in patients with transfusion-dependent beta-thalassemia (TDT).

  • The present study among a Sri Lankan TDT population had their liver fibrosis assessed by FIB-4 score biomarker compared with Transient elastography (TE).

  • Small sample size of the study is one of the major limitations.

  • Even though the liver biopsy is the gold standard method of assessing liver fibrosis, non-invasive TE was used as the reference standard in our study

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a grant from the University Grant Commission, Colombo, Sri Lanka. The grant was awarded under the scheme of Financial assistance for higher studies for university teachers and was granted to carry out a PhD.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical clearance was obtained from the Ethics Review Committee (ERC) of the Faculty of Medicine, University of Kelaniya, Sri Lanka and the study was performed in accordance with the declaration of Helsinki.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 16, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion dependent beta thalassaemia: a cross sectional study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion dependent beta thalassaemia: a cross sectional study
Padmapani Padeniya, Dileepa Ediriweera, Arjuna De Silva, Madunil Niriella, Anuja Premawardhena
medRxiv 2022.01.15.22269369; doi: https://doi.org/10.1101/2022.01.15.22269369
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Using FIB-4 score as a screening tool in the assessment of significant liver fibrosis (F2) in patients with transfusion dependent beta thalassaemia: a cross sectional study
Padmapani Padeniya, Dileepa Ediriweera, Arjuna De Silva, Madunil Niriella, Anuja Premawardhena
medRxiv 2022.01.15.22269369; doi: https://doi.org/10.1101/2022.01.15.22269369

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)